CUPR on Nasdaq
Cuprina Holdings (Cayman) LTD
Cuprina Holdings (Cayman) LTD is an orthopedic company in the Cayman Islands, listed on Nasdaq (CUPR).1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with United Health Products, Inc., Envoy Medical, Inc. or Lifeward Ltd., or pick any stock.
- TickerCUPR on Nasdaq1
- IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
- HeadquartersE91
- Incorporated inCayman Islands2
- Business addressBlock 1090, Lower Delta Road, #06-08, Singapore, U0 1692012
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
Cayman was incorporated as an exempted company in the Cayman Islands on September 22, 2023.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Maggot Debridement Therapy Product brought in 89% of the revenue Cuprina Holdings (Cayman) LTD broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Maggot Debridement Therapy Product | 79.0K SGD | 34.4K SGD | 44.2K SGD |
| Cosmeceutical Product | 21.8K SGD | 13.9K SGD | 5.7K SGD |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue1¢$39.3K
- Research and development5¢$176.4K
- Selling, general and admin94¢$3.6M
- Interest0¢$11.4K
Out of $38.8K in revenue.4 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | 49.9K SGD | 48.3K SGD | 100.8K SGD |
| Cost of revenues | -50.5K SGD | -51.3K SGD | -64.2K SGD |
| Gross profit / (loss) | -645 SGD | -3.0K SGD | 36.6K SGD |
| Selling, general and administrative expenses | -4.6M SGD | -1.4M SGD | -937.2K SGD |
| Research and development costs | -226.9K SGD | -241.4K SGD | -167.7K SGD |
| Total operating expenses | -4.8M SGD | -1.6M SGD | -1.1M SGD |
| Loss from operations | -4.8M SGD | -1.6M SGD | -1.1M SGD |
| Other income | 234.5K SGD | 173.9K SGD | 39.1K SGD |
| Interest expense | -14.7K SGD | -37.2K SGD | -56.6K SGD |
| Total other (expense)/ income, net | 219.7K SGD | 136.7K SGD | -17.4K SGD |
| Loss before tax expense | -4.6M SGD | -1.5M SGD | -1.1M SGD |
| Loss before equity in net earnings of affiliates | -4.6M SGD | -1.5M SGD | -1.1M SGD |
| Equity in net earnings of affiliates | -63.3K SGD | -51.9K SGD | -33.8K SGD |
| Net loss | -4.7M SGD | -1.6M SGD | -1.1M SGD |
| Foreign currency translation, net of income tax | 350.1K SGD | -1.9K SGD | 570 SGD |
| Total comprehensive loss | -4.3M SGD | -1.6M SGD | -1.1M SGD |
| Basic (cents) | -22.83 SGD | -8.68 SGD | -6.22 SGD |
| Diluted (cents) | -22.83 SGD | -8.68 SGD | -6.22 SGD |
| Basic | 20.5M shares | 18.0M shares | 18.0M shares |
| Diluted | 20.5M shares | 18.0M shares | 18.0M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 3.1M SGD | 116.5K SGD | ||
| Accounts receivable, net | 18.2K SGD | 26.4K SGD | ||
| Deferred costs | 1.3M SGD | |||
| Other assets | 4.0M SGD | 146.2K SGD | ||
| Inventories | 1.7K SGD | |||
| Total current assets | 7.3M SGD | 1.7M SGD | ||
| Property and equipment, net | 77.5K SGD | 58.1K SGD | ||
| Right-of-use assets | 316.7K SGD | 30.9K SGD | ||
| Other assets | 779.2K SGD | |||
| Total noncurrent assets | 1.2M SGD | 89.0K SGD | ||
| TOTAL ASSETS | 8.5M SGD | 1.7M SGD | ||
| Accounts payable, net | 1.2K SGD | |||
| Accruals and other payables | 30.6K SGD | 324.0K SGD | ||
| Bank loans, current | 38.7K SGD | 55.2K SGD | ||
| Lease liabilities, current | 110.2K SGD | 35.8K SGD | ||
| Total current liabilities | 3.1M SGD | 6.0M SGD | ||
| Bank loans, non-current | 126.2K SGD | 163.7K SGD | ||
| Lease liabilities, non-current | 207.6K SGD | |||
| Total noncurrent liabilities | 333.8K SGD | 163.7K SGD | ||
| TOTAL LIABILITIES | 3.4M SGD | 6.2M SGD | ||
| Additional paid in capital | 13.9M SGD | 78.7K SGD | ||
| Accumulated deficit | -9.2M SGD | -4.6M SGD | ||
| Accumulated other comprehensive (loss)/ income | 348.5K SGD | -1.6K SGD | ||
| Total shareholders equity (deficit) | 5.1M SGD | -4.5M SGD | -3.0M SGD | -1.8M SGD |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) | 8.5M SGD | 1.7M SGD |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 3.1M SGD | 116.5K SGD | ||
| Accounts receivable, net | 18.2K SGD | 26.4K SGD | ||
| Deferred costs | 1.3M SGD | |||
| Other assets | 4.0M SGD | 146.2K SGD | ||
| Inventories | 1.7K SGD | |||
| Total current assets | 7.3M SGD | 1.7M SGD | ||
| Property and equipment, net | 77.5K SGD | 58.1K SGD | ||
| Right-of-use assets | 316.7K SGD | 30.9K SGD | ||
| Other assets | 779.2K SGD | |||
| Total noncurrent assets | 1.2M SGD | 89.0K SGD | ||
| TOTAL ASSETS | 8.5M SGD | 1.7M SGD | ||
| Accounts payable, net | 1.2K SGD | |||
| Accruals and other payables | 30.6K SGD | 324.0K SGD | ||
| Bank loans, current | 38.7K SGD | 55.2K SGD | ||
| Lease liabilities, current | 110.2K SGD | 35.8K SGD | ||
| Total current liabilities | 3.1M SGD | 6.0M SGD | ||
| Bank loans, non-current | 126.2K SGD | 163.7K SGD | ||
| Lease liabilities, non-current | 207.6K SGD | |||
| Total noncurrent liabilities | 333.8K SGD | 163.7K SGD | ||
| TOTAL LIABILITIES | 3.4M SGD | 6.2M SGD | ||
| Additional paid in capital | 13.9M SGD | 78.7K SGD | ||
| Accumulated deficit | -9.2M SGD | -4.6M SGD | ||
| Accumulated other comprehensive (loss)/ income | 348.5K SGD | -1.6K SGD | ||
| Total shareholders equity (deficit) | 5.1M SGD | -4.5M SGD | -3.0M SGD | -1.8M SGD |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) | 8.5M SGD | 1.7M SGD |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -4.7M SGD | -1.6M SGD | -1.1M SGD |
| Depreciation and amortization | 36.5K SGD | 42.2K SGD | 35.1K SGD |
| Current expected credit loss on account receivables | 28.4K SGD | ||
| Loss on disposal of property and equipment | 2.2K SGD | ||
| Write-off on inventories | 1.7K SGD | 5.9K SGD | |
| Lease related expenses | -3.8K SGD | -2.1K SGD | 106 SGD |
| Foreign exchange loss/ (income) | 141.2K SGD | -1.7K SGD | 2.5K SGD |
| Equity in net earnings of affiliates | 63.3K SGD | 51.9K SGD | 33.8K SGD |
| Account receivables | 8.2K SGD | 24.4K SGD | -37.5K SGD |
| Contract assets | 2.5K SGD | ||
| Other assets and deferred costs | -4.5M SGD | 10.6K SGD | -32.1K SGD |
| Inventories | -1.2K SGD | ||
| Accounts payable | -1.2K SGD | ||
| Accruals and other payables | -291.0K SGD | 123.6K SGD | -45.9K SGD |
| Advance to related parties, net | 39.5K SGD | 69.7K SGD | 238.9K SGD |
| Net cash used in operating activities | -9.1M SGD | -1.2M SGD | -895.0K SGD |
| Purchase of property and equipment | -58.2K SGD | -21.9K SGD | -68.0K SGD |
| Net cash used in investing activities | -58.2K SGD | -21.9K SGD | -68.0K SGD |
| Issuance of ordinary shares | 17.6M SGD | ||
| Payments of financing costs | -2.6M SGD | -423.8K SGD | -647.8K SGD |
| Proceeds from bank loans | 200.0K SGD | ||
| Repayments of bank loans | -54.0K SGD | -23.6K SGD | -20.6K SGD |
| Advance from/ (repayment to) related parties, net | -2.7M SGD | 1.6M SGD | 1.1M SGD |
| Net cash provided by financing activities | 12.2M SGD | 1.3M SGD | 433.1K SGD |
| Net change in cash and cash equivalents | 3.0M SGD | 83.1K SGD | -529.9K SGD |
| Foreign currency translation | -38.4K SGD | -1.9K SGD | 570 SGD |
| Cash paid for interest | 70.6K SGD | 221 SGD | 727 SGD |
| Unpaid deferred offering costs | 242.3K SGD |
No quarter-by-quarter statement was filed.
Corporate structure
Cuprina Holdings (Cayman) LTD sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Cuprina Holdings (Cayman) LTD
- JANE STREET GROUP, LLC Filed SCHEDULE 13G on Cuprina Holdings (Cayman) LTD, latest Jul 28, 2026
- Cuprina Holdings (Cayman) LTD E9
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Cuprina Holdings (Cayman) LTD reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $204.7K4 Dec 31, 2025 | $152.4K5 Dec 31, 2024 | +34.3% |
| Accumulated depreciation | $144.4K4 Dec 31, 2025 | $109.7K5 Dec 31, 2024 | +31.6% |
| Property and equipment, net | $60.3K4 Dec 31, 2025 | $42.7K5 Dec 31, 2024 | +41.2% |
| Operating-lease assets (leased space) | $246.2K4 Dec 31, 2025 | $22.7K5 Dec 31, 2024 | +982.6% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $2.4M4 Dec 31, 2025 | $85.6K5 Dec 31, 2024 | +2730.8% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $1.3K5 Dec 31, 2024 |
Leadership
Who has led Cuprina Holdings (Cayman) LTD, and when. Pick a name to see everywhere that person has worked.
- Chief executive officerDavid Yong Qi Quek Apr 21, 2026 to now6
- Chief financial officerTat Jing Chan Apr 21, 2026 to now7
Board members and other officers (4)
- Board memberDavid Yong Qi Quek Apr 21, 2026 to now6
- Board memberNatasha Kaur Raina Apr 21, 2026 to now8
- Board memberPee Keat Koh Apr 21, 2026 to now9
- Board memberPeng Kwang Teo Apr 21, 2026 to now10
Timeline
- Apr 21, 2026New chief executive David Yong Qi Quek becomes CEO6
Filings
101 filings to the SEC since October 2021: 3 annual reports, 7 insider forms, 1 large holders, 90 other. The latest 20:
- Oct 2, 20266-K EDGAR
- Sep 29, 20266-K EDGAR
- Sep 18, 20266-K EDGAR
- Sep 18, 20266-K EDGAR
- Sep 16, 2026424B4 EDGAR
- Sep 15, 2026EFFECT EDGAR
- Sep 11, 2026F-1/A EDGAR
- Jul 28, 2026SCHEDULE 13G EDGAR
- Jul 7, 2026F-1 EDGAR
- Jul 1, 202620-F/A EDGAR
- Jun 15, 20266-K EDGAR
- Jun 12, 20266-K EDGAR
- Jun 5, 2026DRS EDGAR
- May 14, 20266-K EDGAR
- Apr 28, 20266-K/A EDGAR
- Apr 27, 202620-F EDGAR
- Apr 21, 20263 EDGAR
- Apr 21, 20263 EDGAR
- Apr 21, 20263 EDGAR
- Apr 21, 20263 EDGAR
The 101 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- JANE STREET GROUP, LLCSCHEDULE 13G, 1 filing Jul 28, 202611
SEC filer profile
How Cuprina Holdings (Cayman) LTD is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCuprina Holdings (Cayman) LTD1
- CIK0001995704
- Filer statusNon-accelerated filer an emerging growth company; a shell company3
- Incorporated inCayman Islands3
- Fiscal year endsDecember 311
- Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressBlock 1090, Lower Delta Road, #06-08, Singapore, U0 1692011
- Phone(65) 8512 72751
- Shares outstanding7,365,000 shares as of Apr 27, 20263
- AuditorKreit & Chiu CPA LLP, Los Angeles, California PCAOB ID 6651; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceOct 13, 20231
- Filings101 in all: 6-K (22), CORRESP (14), F-1/A (13), UPLOAD (12), 3 (7), DRSLTR (5), DRS/A (4), EFFECT (3)1
All 21 form types
F-1 (3), 20-F (2), 424B4 (2), 8-A12B (2), DRS (2), RW (2), SEC STAFF LETTER (2), 20-F/A (1), 6-K/A (1), CERT (1), FWP (1), NT 20-F (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (20-F) Apr 27, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Class A Ordinary shares, par value US$0.001 per share | CUPR | Nasdaq |
From the cover page of the 20-F filed Apr 27, 2026 (Section 12(b) of the Exchange Act).3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARNatasha Kaur Raina, Board member
- 9SEC EDGARPee Keat Koh, Board member
- 10SEC EDGARPeng Kwang Teo, Board member
- 11